Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5008

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5008 3)

Label for Atorvastatin Calcium 10 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The package contains 30 tablets. Tablets are elliptical, white, debossed with '10' on one side and 'ATS' on the other. The label includes NDC 68071-5008, manufacturer details, storage instructions, and regulatory warnings.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph depicting cumulative incidence percentage over approximately 3.5 years for Atorvastatin compared to Placebo. The solid line represents Atorvastatin with lower cumulative incidence than the dashed Placebo line, showing a hazard ratio (HR) of 0.64 with confidence interval (0.50-0.83) and p-value 0.0005.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A cumulative hazard graph comparing Atorvastatin and placebo over four years. The x-axis shows time to first primary endpoint in years up to 5 years, and the y-axis shows cumulative hazard percentage up to 15%. The graph has two lines: a solid line for Atorvastatin and a dashed line for placebo, with Atorvastatin showing a lower cumulative hazard. A hazard ratio (HR) of 0.63 with a confidence interval (0.48-0.83) and p=0.001 is noted on the chart.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph depicting the percentage of subjects experiencing an event over time up to 5 years. It compares Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line), showing fewer events with the 80 mg dose. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including phenyl groups, fluorophenyl group, hydroxyl groups, and calcium ion coordination with waters of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.